Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics.
about
The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate CancerGraft-versus-host disease biomarkers: omics and personalized medicineProteomic tools to decipher microbial community structure and functioningApplications of targeted proteomics in systems biology and translational medicineInnovations in proteomic profiling of cancers: alternative splice variants as a new class of cancer biomarker candidates and bridging of proteomics with structural biologyProteomics in India: the clinical aspectAdvances in targeted proteomics and applications to biomedical researchTargeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patientsDifferential diagnosis of azoospermia with proteomic biomarkers ECM1 and TEX101 quantified in seminal plasmaHuman SRMAtlas: A Resource of Targeted Assays to Quantify the Complete Human ProteomeDesign, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS)Automated selected reaction monitoring data analysis workflow for large-scale targeted proteomic studies.Building high-quality assay libraries for targeted analysis of SWATH MS data.Identification of a Set of Conserved Eukaryotic Internal Retention Time Standards for Data-independent Acquisition Mass SpectrometryMultiplexed, Scheduled, High-Resolution Parallel Reaction Monitoring on a Full Scan QqTOF Instrument with Integrated Data-Dependent and Targeted Mass Spectrometric Workflows.Advancing Urinary Protein Biomarker Discovery by Data-Independent Acquisition on a Quadrupole-Orbitrap Mass SpectrometerReproducible quantitative proteotype data matrices for systems biology.Data-Driven Approach To Determine Popular Proteins for Targeted Proteomics Translation of Six Organ SystemsUrine sample preparation in 96-well filter plates for quantitative clinical proteomics.Data-Independent Acquisition and Parallel Reaction Monitoring Mass Spectrometry Identification of Serum Biomarkers for Ovarian Cancer.A blood-based proteomic classifier for the molecular characterization of pulmonary nodules.Bacterial protein signals are associated with Crohn's disease.Antibody-independent targeted quantification of TMPRSS2-ERG fusion protein products in prostate cancer.Expediting SRM assay development for large-scale targeted proteomics experiments.A complete mass-spectrometric map of the yeast proteome applied to quantitative trait analysis.N-glycoprotein SRMAtlas: a resource of mass spectrometric assays for N-glycosites enabling consistent and multiplexed protein quantification for clinical applications.Contextualised urinary biomarker analysis facilitates diagnosis of paediatric obstructive sleep apnoeaModules, networks and systems medicine for understanding disease and aiding diagnosis.Label-free quantitative urinary proteomics identifies the arginase pathway as a new player in congenital obstructive nephropathy.Global analysis of cellular proteolysis by selective enzymatic labeling of protein N-termini.Animal board invited review: advances in proteomics for animal and food sciencesQuantitative variability of 342 plasma proteins in a human twin population.Opportunities and challenges of proteomics in pediatric patients: circulating biomarkers after hematopoietic stem cell transplantation as a successful example.Derivative component analysis for mass spectral serum proteomic profiles.Using data-independent, high-resolution mass spectrometry in protein biomarker research: perspectives and clinical applications.Evaluating kinase ATP uptake and tyrosine phosphorylation using multiplexed quantification of chemically labeled and post-translationally modified peptides.Discovery and targeted proteomics on cutaneous biopsies infected by borrelia to investigate lyme disease.Proteomics in cancer biomarkers discovery: challenges and applications.Quantitative mass spectrometric profiling of cancer-cell proteomes derived from liquid and solid tumors.Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition.
P2860
Q26738703-74DB0855-25BD-4347-A73D-06B5B83E4B3AQ26824540-3C72ECC6-7BB8-4C37-A4B6-548DBF15D425Q26852225-D44FCBDB-CDE9-4723-A7FD-03197E411F82Q26852271-E244381E-E30B-4161-9052-7EEA9C716DA3Q27011213-2CCE9457-EDF7-42C0-B42C-9B8229CC3631Q28066363-6505F99C-040C-4016-9B6E-54B7C8217C35Q28066912-C53601D1-11DE-41AF-882B-E537896BA772Q28085015-1453E8A2-3421-4B87-B986-75FAE78E0B1CQ28302387-C3897276-1B56-406A-BE47-61A2A76E03A8Q28468274-7985EEC5-7301-462B-9B6C-7B4CEA609B88Q28681060-B302C445-5791-4A9F-AB54-AFCC01471439Q30657369-4699DD69-C21C-4CD4-AF7B-2D88D5831530Q30891496-2E4C142B-97DB-4AF7-8665-91080111AEFEQ30982025-EC3FE8F6-9A59-45C2-A7D1-84094ED8236BQ30996203-BDE6F0C2-DC9C-4F00-AC53-E06E8E287AD1Q30999645-56824EFD-88C2-49A0-B947-1CCE6FAA3695Q31018998-78D3E4CC-2E8F-451C-A71D-5FD3E78776C1Q31111295-30954512-4717-4D34-902D-B2B55BC16CA4Q33710494-6D57DD5B-08A6-4793-99BE-385B660E4A9FQ33773348-D18071BA-13F4-4D6C-9A36-39E36CBC4CCEQ33968948-507B3EC5-05CA-4357-84A1-E97BB85A27D9Q34237245-410C9ECA-19C8-48B2-B5D9-FB43AB18F6F2Q34283031-38290C0F-61B3-4ADA-A88F-ACC7E8CADA39Q34286018-2492D38A-E4CD-4815-B500-F6A7753F5423Q34555110-78D658D6-A156-4F76-934E-891494AC1102Q34585592-DCFDB84A-79B0-4DC4-BCAC-70C75BCAF3BDQ34586288-E0FA191B-68DB-4865-9CA6-13AB304D0E4CQ34624769-77B17C94-2284-4409-9E0A-608AC641E46BQ34634938-9C8B9626-A064-4C3D-A4AF-C1C5907B9189Q34663327-06664E8E-E8B9-4DD9-ADCE-63E269FFAB06Q34992882-3C94F56C-413D-4FBE-B1D4-402C58722ECEQ35174121-DE08F577-E0C6-4091-B36D-95741552CCA2Q35180727-BE85C2BB-D59A-4373-9C0D-6182005DF285Q35216609-81DD730E-8E34-433F-AFF7-882245951260Q35518214-09F0AFFE-839D-498D-8C60-81DC0832A852Q35579916-5A6DF5F3-38E7-4B3E-84C3-AB5578B1806BQ35583325-62DFCDFA-E488-4888-AEF3-B8002B5BAB70Q35592114-FBF62811-5994-4E70-9538-BB5C04AB5C78Q35600155-53470B40-44F8-4CDA-B101-E4A9E7B51A20Q35847101-FCC5EE2B-A7C6-412B-A3B5-CA9DA53CC963
P2860
Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Reproducible quantification of ...... ids using targeted proteomics.
@ast
Reproducible quantification of ...... ids using targeted proteomics.
@en
Reproducible quantification of ...... ids using targeted proteomics.
@nl
type
label
Reproducible quantification of ...... ids using targeted proteomics.
@ast
Reproducible quantification of ...... ids using targeted proteomics.
@en
Reproducible quantification of ...... ids using targeted proteomics.
@nl
prefLabel
Reproducible quantification of ...... ids using targeted proteomics.
@ast
Reproducible quantification of ...... ids using targeted proteomics.
@en
Reproducible quantification of ...... ids using targeted proteomics.
@nl
P2093
P2860
P50
P1476
Reproducible quantification of ...... ids using targeted proteomics.
@en
P2093
Atul Sethi
Emma Niméus-Malmström
Martin Soste
Nathalie Selevsek
Oliver Rinner
Robert L Moritz
Ruth Hüttenhain
Terry Farrah
P2860
P304
P356
10.1126/SCITRANSLMED.3003989
P407
P577
2012-07-01T00:00:00Z